Plasma cystatin C concentration in non-insulin-dependent diabetes mellitus: Relation with nephrophathy

Archivum Immunologiae et Therapiae Experimentalis

Volumn 47, Issue 5, 1999, Pages 327-331

  Piwowar, Agnieszka ^a   Knapik Kordecka, Maria ^a   Buczyńska, Henryka ^a   Warwas, Maria ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

2 microglobulin; Cystatin c; Diabetic nephropathy; N acetyl d glucosaminidase

Indexed keywords

ACETYLGLUCOSAMINIDASE; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CREATININE; CYSTATIN; CYSTATIN C; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ALBUMINURIA; ARTICLE; BLOOD; DIABETIC NEPHROPATHY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; URINE;

ACETYLGLUCOSAMINIDASE; ADULT; AGED; ALBUMINURIA; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CREATININE; CYSTATINS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED;

EID: 0033251129     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. BÖKENKAMP A., DOMANETZKI M., ZINCK R., SCHUMANN G., BYRD D. and BRODEHL J. (1998): Cystatin C - a new marker of glomerular filtration rate in children independent of age and height. Pediatrics, 101, 875-881.
2. CHOWDHURY T. A., BARNETT A. H. and BAIN S. C. (1996): Pathogenesis of diabetic nephropathy. Trends Endocrinol. Metab., 7, 320-323.
3. DEFERRARI G., REPETTO M., CALVI C., CIABATTONI M., ROSSI C. and ROBAUDO C. (1998): Diabetic nephropathy: from micro-to macroalbuminuria. Nephrol. Dial. Transplant., 13, (suppl. 8), 11-15.
4. DI LANDRO D., CATALANO C., LAMBERTINI D., BORDIN V., FABBIAN F., NASO A. and ROMAGNOLI G. F. (1998): The effect of metabolic control on development and progression of diabetic nephropathy. Nephrol. Dial. Transplant., 13, (suppl. 8), 35-43.
5. DOUMAS B. T. and PETERS T. JR. (1997): Serum and urine albumin: a progress report on their measurement and clinical significance. Clin. Chim. Acta, 258, 3-20.
6. ERLANDSEN E. J., RANDERS E. and KRISTENSEN J. H. (1998): Reference intervals for serum cystatin C and serum creatinine in adults. Clin. Chem. Lab. Med., 36, 393-397.
7. EROSS J., KREUTZMANN D., JIMENEZ M., KEEN R., ROGERS S., COWELL C., VINES R. and SILINK M. (1984): Colorimetric measurement of glycosylated protein in whole blood, red cells, plasma and dried blood. Ann. Clin. Biochem., 21, 477-483.
8. 2-microglobulin as a measure of glomerular filtration rate. Acta Med. Scand., 218, 499-503.
9. HENSKENS Y. M. C., VEERMAN E. I. C. and NIEUW AMERONGEN A. V. (1996): Cystatins in health and disease. Biol. Chem. Hoppe-Seyler, 377, 71-86.
10. ISHII N., OGAWA Z., ITOH H., IKENAGA H. and SARUTA T. (1994-95): Diagnostic significance of urinary enzymes for diabetes mellitus and hypertension. Enzyme Protein, 48, 174-182.
11. JUNG K. and JUNG M. (1995): Cystatin C: a promising marker of glomerular filtration rate to replace creatinine. Nephron, 70, 370-371.
12. JUNG K., SCHULZE B. D., SYDOW K., PERGANDE M., PRECHT K. and SCHREIBER G. (1987): Diagnostic value of low-molecular mass proteins in serum for detection of reduced glomerular filtration rate. J. Clin. Chem. Clin. Biochem., 25, 499-503.
13. KEEVIL B. G., KILPATRICK E. S., NICHOLS S. P. and MAYLOR P. W. (1998): Biological variation of cystatin C: implications for the assessment of glomerular filtration rate. Clin. Chem., 44, 1535-1539.
14. KYHSE-ANDERSEN J., SCHMIDT C., NORDIN G., ANDERSSON B., NILSSON-EHLE P., LINDSTRÖM V. and GRUBB A. (1994): Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin. Chem., 40, 1921-1926.
15. MIRALLES J. M., CORALLES I. I., GARCIA-DIEZ L. C., CABEZAS I. A. and KOGLERO A. (1982): N-acetyl β-D-glucosaminidase and α-L-fucosidase activities in relation to glycosylated hemoglobin levels and retinopathy in diabetes. Clin. Chim. Acta, 121, 373-378.
16. NEWMAN D. J., THAKKAR H., EDWARDS R. G., WILKIE M., WHITE T., GRUBB A. and PRICE C. P. (1995): Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int., 47, 312-318.
17. 2-microglobulin/cystatin C-ratio. Scand. J. Clin. Lab. Invest., 57, 463-470.
18. PEREZ-BLANCO F. J., SABATEL-HERNANDEZ G., CANTERO-HINOJOSA J. and RODRIGUEZ-CUAERTERO A. (1998): Urinary N-acetyl-β-glucosaminidase excretion in non-insulin-dependent diabetes mellitus: relation with diabetic nephropathy. Clin. Nephrol., 49, 132-134.
19. REMUZZI G., RUGGENENTI P. and BENIGNI A. (1997): Understanding the nature of renal disease progression. Kidney Int., 51, 2-15.
20. SCHOSINSKY K. H., VARGAS M., ESQUIVEL A. L. and CHAVARRIA A. (1987): Simple spectrophotometric determination of urinary albumin by dye-binding with use of bromphenol blue. Clin. Chem., 33, 223-226.
21. SECO M. L., RUS A., SIERRA M., CABALLERO M. and BORQUE L. (1999): Determination of serurn cystatin C in patients with essential hypertension. Nephron, 81, 446-447.
22. TIAN S., KUSANO E., OHARA T., TABEI K., ITOH Y., KAWAI T. and ASANO Y. (1997): Cystatin C measurement and its practical use in patients with various renal diseases. Clin. Nephrol., 48, 104-108.